Table 3.
Determinants | Model 1 |
Model 2 |
Model 3 |
||
---|---|---|---|---|---|
OR (95% CI) | OR (95% CI) | p value | OR (95% CI) | p value | |
IVC expiration index, mm/m2 | 1.09 (1.00,1.18)∗ | 1.13 (1.03–1.23) | 0.01 | ||
Serum albumin, g/dl | 0.73 (0.40–1.30) | 0.3 | 0.76 (0.42–1.38) | 0.4 | |
Antihypertensive use | <0.0001 | <0.0001 | |||
0 antihypertensives | 1.00 (réf. cat.) | 1.00 (réf. cat.) | |||
1 antihypertensive | 1.40 (0.66–2.96) | 0.4 | 1.41 (0.66–3.00) | 0.4 | |
2 antihypertensives | 3.15 (1.52–6.53) | <0.01 | 3.19 (1.52–6.70) | <0.01 | |
3 antihypertensives | 4.85 (2.06–11.43) | <0.001 | 5.28 (2.21–12.61) | <0.001 | |
≥4 antihypertensives | 5.24 (2.31–11.92) | <0.0001 | 5.58 (2.42–12.88) | <0.0001 | |
Vitamin D receptor activator use | yes/no | 2.78 (1.56–4.97) | <0.001 | 3.07 (1.70–5.55) | <0.001 |
LR χ2 | 4.10 | 40.87 | 47.97 | ||
Pseudo r2 | 0.01 | 0.11 | 0.13 | ||
LR test vs. model 1 | <0.0001 | ||||
LR test vs. model 2 | <0.01 |
p = 0.05.